Smith & Nephew (SNN) Still Seen as Takeover Target Amid Medtronic/Covidien Deal - Summer Street
Tweet Send to a Friend
Summer Street analyst Mark Landy reiterated a Buy rating and $112 price target on Smith & Nephew (NYSE: SNN) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
